Ophthalmic Ointment Prescription Recommendation
For general ocular lubrication, prescribe preservative-free erythromycin 0.5% ophthalmic ointment or white soft paraffin ointment applied to the affected eye(s) at bedtime (qhs). 1, 2
Specific Formulations and Dosing
For Dry Eye/Ocular Surface Disease
- Preservative-free lubricating ointment (white soft paraffin or similar): Apply to affected eye(s) at bedtime
- Sig: "Apply a small amount (approximately ½ inch ribbon) to the lower eyelid margin of affected eye(s) at bedtime"
- Ointments are specifically recommended for overnight symptom control because they are thicker than artificial tears and provide prolonged lubrication 2
Important caveat: Ointments cause temporary blurred vision, so bedtime application is standard. Morning lid hygiene should follow to prevent blepharitis 2
For Bacterial Prophylaxis or Blepharitis
- Bacitracin ophthalmic ointment or erythromycin 0.5% ophthalmic ointment: Apply to eyelid margins 1-4 times daily or at bedtime 3
- Sig: "Apply a small amount to the eyelid margins of affected eye(s) [frequency] daily for [duration based on severity]"
- Single-use tubes of erythromycin 0.5% are the standard prophylactic agent 4
For Severe Ocular Surface Conditions
In Stevens-Johnson syndrome/toxic epidermal necrolysis, white soft paraffin ointment is applied every 2 hours during acute illness 5
Key Clinical Considerations
Preservative-free formulations are mandatory when:
- Using ointments more than 4 times daily
- Poor ocular surface condition exists (severe corneal epithelial defects or superficial punctate keratopathy)
- Patient has chronic dry eye requiring frequent applications 1
Ointments have limited corneal penetration due to poor solubility, making them unsuitable as primary treatment for bacterial keratitis but useful for adjunctive bedtime therapy in less severe cases 6, 7
Common pitfall: Prescribing preserved ointments for chronic use. Preservatives cause significant ocular surface toxicity with repeated exposure, particularly affecting meibomian gland epithelial cells, conjunctival epithelial cells, and corneal epithelial cells 8, 9. The evidence strongly favors preservative-free formulations for any chronic ophthalmic therapy 10, 11, 12, 13.